Business Wire

BearingPoint client success story: Driving digital continuity in product development through a data management hub

3.4.2025 11:08:00 CEST | Business Wire | Press Release

Share

As vehicle development becomes increasingly complex with the transition to electromobility and the integration of software across almost all components, seamless coordination among specialized departments involved is more critical than ever. At the same time, competitive pressures demand shorter development cycles, making traditional methods of data exchange, such as point-to-point interfaces or manual processes, less efficient and prone to inconsistencies. However, a high level of data consistency is essential to ensure smooth development, integration, and validation, particularly in the development of electric control units and onboard communication systems.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250403719346/en/

BearingPoint is supporting BMW Group in establishing a central data hub to create a high-quality data foundation for the electrical/electronics (E/E) development process to enable cross-departmental digital continuity and shorter time-to-market.

Establishing a central master data hub for electrics/electronics development

To tackle these challenges, BMW Group initiated the development of a central master data hub for the E/E development process and entrusted BearingPoint with the functional conceptualization of the master data portfolio as well as the technical integration and operations. Relevant data is imported from the IT system where it is generated, and it is also harmonized both from a functional and technical perspective before being linked to other data. Then, it is distributed to all IT systems whose users require it for their product development activities. The project team built robust yet flexible standard interfaces that significantly streamline data exchange.

Together with the general platform development and technical integration of the new hub with more than 70 IT systems, BearingPoint continuously supports the BMW Group in the functional harmonization of the distributed data. This approach was crucial to meet the different needs and perspectives of various departments in developing electric control units. Additionally, the quality of processed data is proactively ensured to prevent the distribution of inaccurate records across the organization.

“By working closely with BMW Group, we’ve developed a solution that enables digital continuity and significantly strengthens cross-departmental collaboration, to address the complexities of modern vehicle development. It reflects the transformative potential of high-quality and, most importantly, available master data on business processes which originates in combining cutting-edge technology with the right data strategy,” said Patrick Kirchhof, Partner at BearingPoint.

Accelerating time-to-market and data quality improvements

The BMW Group’s centrally provisioned data hub has increased the efficiency of the product development process at the BMW Group, enabling seamless collaboration between numerous departments based on a unified, up-to-date, and high-quality data foundation. The hub supports faster development cycles in these times of constantly increasing vehicle complexity. Additionally, the central hub simplifies the IT landscape by reducing point-to-point interfaces, which helps reduce development and maintenance costs. Overall, the solution contributes to the continuous optimization of the product development process.

The full client story is available here: https://www.bearingpoint.com/en/insights-events/client-stories/bmw-group/

About BearingPoint

BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.

BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.

BearingPoint is a certified B Corporation, meeting high standards of social and environmental impact.

For more information, please visit:

Homepage: www.bearingpoint.com
Data Quality Navigator: https://dataqualitynavigator.com
LinkedIn: www.linkedin.com/company/bearingpoint

View source version on businesswire.com: https://www.businesswire.com/news/home/20250403719346/en/

Contacts

Press contact

Alexander Bock
Global Senior Manager Communications
Telephone: +49 89 540338029
Email: alexander.bock@bearingpoint.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye